JPH0314315B2 - - Google Patents

Info

Publication number
JPH0314315B2
JPH0314315B2 JP59229029A JP22902984A JPH0314315B2 JP H0314315 B2 JPH0314315 B2 JP H0314315B2 JP 59229029 A JP59229029 A JP 59229029A JP 22902984 A JP22902984 A JP 22902984A JP H0314315 B2 JPH0314315 B2 JP H0314315B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
alkyl
furo
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59229029A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60112793A (ja
Inventor
Esanu Andore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of JPS60112793A publication Critical patent/JPS60112793A/ja
Publication of JPH0314315B2 publication Critical patent/JPH0314315B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP59229029A 1983-11-16 1984-11-01 ６―ビニル―フロー（３，４―ｃ）―ピリジン誘導体，その製造法及びそれを含有する利尿組成物 Granted JPS60112793A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838330517A GB8330517D0 (en) 1983-11-16 1983-11-16 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330517 1983-11-16

Publications (2)

Publication Number Publication Date
JPS60112793A JPS60112793A (ja) 1985-06-19
JPH0314315B2 true JPH0314315B2 (enExample) 1991-02-26

Family

ID=10551816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59229029A Granted JPS60112793A (ja) 1983-11-16 1984-11-01 ６―ビニル―フロー（３，４―ｃ）―ピリジン誘導体，その製造法及びそれを含有する利尿組成物

Country Status (25)

Country Link
US (1) US4569939A (enExample)
JP (1) JPS60112793A (enExample)
AT (1) AT391867B (enExample)
BE (1) BE900942A (enExample)
CA (1) CA1257271A (enExample)
CH (1) CH660738A5 (enExample)
DE (1) DE3442035A1 (enExample)
DK (1) DK157870C (enExample)
DZ (1) DZ701A1 (enExample)
ES (1) ES537665A0 (enExample)
FI (1) FI79852C (enExample)
FR (2) FR2554719B1 (enExample)
GB (2) GB8330517D0 (enExample)
HK (1) HK36087A (enExample)
IE (1) IE58005B1 (enExample)
IT (1) IT1213246B (enExample)
LU (1) LU85635A1 (enExample)
MA (1) MA20259A1 (enExample)
MY (1) MY101721A (enExample)
NL (1) NL8403353A (enExample)
OA (1) OA07864A (enExample)
PT (1) PT79511B (enExample)
SE (1) SE458116B (enExample)
SG (1) SG6687G (enExample)
ZA (1) ZA848130B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
EP0511163B1 (de) * 1991-04-24 1995-07-26 Ciba-Geigy Ag Fliessfähige wässrige Dispersionen von Polycarbonsäure-Korrosionsinhibitoren
ES2250112T3 (es) 1999-03-08 2006-04-16 Medicure Inc. Analogos de piridoxal para el tratamiento de trastornos causados por carencia de vitamina b6.
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
AU2001237185B2 (en) 2000-02-29 2006-02-02 Medicure International Inc. Cardioprotective phosphonates and malonates
WO2001072309A2 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
WO2002004421A2 (en) 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
CA2585165A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤
CN116365023A (zh) * 2021-12-23 2023-06-30 宁德国泰华荣新材料有限公司 一种锂离子电池电解液及使用该电解液的锂离子电池

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
GB2008582B (en) * 1977-11-25 1982-04-28 Scras Pyridine derivative
IN156817B (enExample) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
SE458116B (sv) 1989-02-27
DZ701A1 (fr) 2004-09-13
DE3442035A1 (de) 1985-05-30
DK542584D0 (da) 1984-11-15
FR2554719A1 (fr) 1985-05-17
NL8403353A (nl) 1985-06-17
LU85635A1 (fr) 1985-06-04
FR2554817A1 (fr) 1985-05-17
GB2149782B (en) 1986-10-22
FI79852B (fi) 1989-11-30
FR2554817B1 (fr) 1986-04-18
SG6687G (en) 1987-06-05
ES8600299A1 (es) 1985-09-16
MY101721A (en) 1992-01-17
ZA848130B (en) 1985-06-26
CH660738A5 (fr) 1987-06-15
IT1213246B (it) 1989-12-14
JPS60112793A (ja) 1985-06-19
US4569939A (en) 1986-02-11
FR2554719B1 (fr) 1986-06-06
FI844279L (fi) 1985-05-17
HK36087A (en) 1987-05-08
DK157870C (da) 1990-08-06
FI79852C (fi) 1990-03-12
ES537665A0 (es) 1985-09-16
IE58005B1 (en) 1993-06-02
IT8423565A0 (it) 1984-11-14
PT79511A (en) 1984-12-01
GB8330517D0 (en) 1983-12-21
OA07864A (fr) 1986-11-20
SE8405710D0 (sv) 1984-11-14
ATA364384A (de) 1990-06-15
DK157870B (da) 1990-02-26
AT391867B (de) 1990-12-10
GB8426490D0 (en) 1984-11-28
IE842930L (en) 1985-05-16
SE8405710L (sv) 1985-05-17
FI844279A0 (fi) 1984-11-01
PT79511B (en) 1986-09-08
DK542584A (da) 1985-05-17
CA1257271A (en) 1989-07-11
MA20259A1 (fr) 1985-07-01
GB2149782A (en) 1985-06-19
BE900942A (fr) 1985-02-15

Similar Documents

Publication Publication Date Title
JPH0314315B2 (enExample)
EP0028834B1 (en) Imidazole-5-acetic acid derivatives, their production and use
US3711489A (en) Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
US4048182A (en) Derivatives of imidazo [4,5-b]pyridines
SU568366A3 (ru) Способ получени производных бензодиазепина или их 5-окисей или солей
EP0120558B1 (en) Antihypertensive n-piperazinylalkanoylanilides
EP0147915B1 (en) New azulene derivatives useful as anti-ulcerative and anti-flammatory agents
EP0055068B1 (en) Quinolone derivatives and their use as pharmaceuticals
EP0051215A2 (en) Methods and intermediates for the synthesis of 3-aryl-3-hydroxy-phthalimidines
KR910001135B1 (ko) 피라졸로[1,5-a]피리딘 유도체의 제조방법
US4036983A (en) Ferrocene compounds and pharmaceutical composition for use in treatment of iron deficiency in an animal
US4012373A (en) Pyrazolo[3',4'-2,3]pyrido[4,5-e]b-benzo-1,5-diazepinones
JPS5849369A (ja) 新規のイミダゾール化合物
US3156697A (en) Pyridylcoumarins
US4108894A (en) Amidines
JPH0256478A (ja) ２，３，４，５―テトラヒドロ―１―ベンズオキセピン―３，５―ジオン誘導体及びその製法
US4355166A (en) Quinuclidinic ester and derivatives of phenoxycarboxylic acids
EP0132814A1 (en) Ester derivative of substituted acetic acid and preparing the same
JPS5810387B2 (ja) ４，５，６，７テトラヒドロイミダゾ〔４，５−ｃ〕ピリジン誘導体及びその製法
US3876788A (en) Heterocyclic compounds in the treatment of inflammatory of arthritic conditions
IL34468A (en) Acidic salt salts of the history of indonopyridine, their preparation and pharmaceutical preparations containing them
US3978081A (en) 11H,12H-[1]benzopyrano[2,3-b][1]benzopyran-11,12-dione and derivatives
JPS61180761A (ja) ６−置換アズレン誘導体スルホン酸塩，抗潰瘍剤及びその製造方法
JPH0780812B2 (ja) アズレン誘導体トロンボキサンシンセタ−ゼ阻害剤及びその製法
KR820000495B1 (ko) 퀴나졸린 유도체의 제조방법